Is 0.15 mmol/kg of contrast agent effective for delayed-enhancement magnetic resonance imaging at 1.5 T?

被引：0
|
作者：
Ma, Heng [1 ]
Yang, Jun [1 ]
Wang, Yong [2 ]
Wen, Zhaoying [3 ]
Liu, Ying [4 ]
Liu, Jing [1 ]
Wang, Bin [5 ]
机构：
[1] Yuhuangding Hosp, Yantai 264000, Shandong, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp, Shanghai 200030, Peoples R China
[3] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China
[4] Fourth Mil Med Univ, Xijing Hosp, Xian, Shaanxi, Peoples R China
[5] Binzhou Med Univ, Shandong Prov Characterist Key Subject Med Imagin, Yantai, Shandong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2014年 / 174卷 / 01期
关键词：
Late enhancement; Contrast dose; Cardiac magnetic resonance imaging; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; 3.0T;
D O I：
10.1016/j.ijcard.2014.04.039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：226 / 226
页数：1
相关论文
共 50 条
  • [1] Delayed-enhancement magnetic resonance imaging at 3.0T using 0.15 mmol/kg of contrast agent for the assessment of chronic myocardial infarction
    Yang, Jun
    Ma, Heng
    Liu, Jing
    Wang, Chunxiao
    Shi, Yinghong
    Xie, Haizhu
    Huo, Futao
    Liu, Fengli
    Lin, Kai
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (05) : 778 - 782
  • [2] Enhancement of cerebral diseases: How much contrast agent is enough? Comparison of 0.1, 0.2, and 0.3 mmol/kg gadoteridol at 0.2 T with 0.1 mmol/kg gadoteridol at 1.5 T
    Brekenfeld, C
    Foert, E
    Hundt, W
    Kenn, W
    Lodeann, KP
    Gehl, HB
    INVESTIGATIVE RADIOLOGY, 2001, 36 (05) : 266 - 275
  • [3] Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance imaging
    Cury, RC
    Abbara, S
    Sandoval, LJD
    Houser, S
    Brady, TJ
    Palacios, IF
    CIRCULATION, 2005, 111 (09) : E115 - E117
  • [4] Breast lesion detection and characterization with contrast-enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
    Clauser, Paola
    Helbich, Thomas H.
    Kapetas, Panagiotis
    Pinker, Katja
    Bernathova, Maria
    Woitek, Ramona
    Kaneider, Andreas
    Baltzer, Pascal A. T.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 49 (04) : 1157 - 1165
  • [5] Brain MRI With Single-Dose (0.1 mmol/kg) Gadobutrol at 1.5 T and 3 T: Comparison With 0.15 mmol/kg Gadoterate Meglumine
    Kramer, Harald
    Runge, Val M.
    Naul, L. Gill
    Loynachan, Alan T.
    Reiser, Maximilian F.
    Wintersperger, Bernd J.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05) : 1337 - 1342
  • [6] Technology Insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging
    Robert M Judd
    Anja Wagner
    Wolfgang G Rehwald
    Timothy Albert
    Raymond J Kim
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 150 - 158
  • [7] Technology Insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging
    Judd, RM
    Wagner, A
    Rehwald, WG
    Albert, T
    Kim, RJ
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (03): : 150 - 158
  • [8] Use of delayed-enhancement magnetic resonance imaging for fibrosis detection in the atria: a review
    Pontecorboli, Giulia
    Figueras i Ventura, Rosa M.
    Carlosena, Alicia
    Benito, Eva
    Prat-Gonzales, Susanna
    Padeletti, Luigi
    Mont, Lluis
    EUROPACE, 2017, 19 (02): : 180 - 189
  • [9] Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: Interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T
    Attenberger, Ulrike I.
    Michaely, Henrik J.
    Wintersperger, Bernd J.
    Sourbron, Steven P.
    Lodemann, Klaus-Peter
    Reiser, Maximilian F.
    Schoenberg, Stefan O.
    EUROPEAN RADIOLOGY, 2008, 18 (06) : 1260 - 1268
  • [10] Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: Interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T
    Ulrike I. Attenberger
    Henrik J. Michaely
    Bernd J. Wintersperger
    Steven P. Sourbron
    Klaus-Peter Lodemann
    Maximilian F. Reiser
    Stefan O. Schoenberg
    European Radiology, 2008, 18 : 1260 - 1268
12345